<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2018-4-28-35</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-2328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>САХАРНЫЙ ДИАБЕТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DIABETES MELLITUS</subject></subj-group></article-categories><title-group><article-title>Панкреатогенный сахарный диабет/сахарный диабет типа 3с: современное состояние проблемы</article-title><trans-title-group xml:lang="en"><trans-title>Pancreatogenic diabetes / type 3c diabetes: status update on the problem</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Руяткина</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ruiatkina</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор</p></bio><bio xml:lang="en"><p>MD, Prof.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Руяткин</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ruiatkin</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук</p></bio><bio xml:lang="en"><p>PhD in medicine</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Новосибирский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>29</day><month>03</month><year>2018</year></pub-date><volume>0</volume><issue>4</issue><fpage>28</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Руяткина Л.А., Руяткин Д.С., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Руяткина Л.А., Руяткин Д.С.</copyright-holder><copyright-holder xml:lang="en">Ruiatkina L.A., Ruiatkin D.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/2328">https://www.med-sovet.pro/jour/article/view/2328</self-uri><abstract><p>Одним из важных условий персонализированного выбора адекватной терапии в современной диабетологии является точный дифференциальный диагноз типа сахарного диабета (СД). Особое внимание в этом плане привлекает вторичный СД вследствие целой группы гетерогенных экзокринных заболеваний поджелудочной железы (ПЖ), объединенных в классификационных целях при разном патогенезе, с лидирующей ролью хронического панкреатита (ХП). В обзоре литературы представлен интегральный взгляд на проблему на основе анализа современных диабетологических и гастроэнтерологических гайдлайнов. Представлена терминологическая трансформация этого диабета в СД типа 3с, обсуждена проблема оценки его распространенности. Рассматриваются клинические особенности в тесной связи с патогенетическими, представляя СД типа 3с как особую морфофункциональную единицу с акцентом на высокий риск протоковой аденокарциномы ПЖ. Обсуждаются сложности его верификации в тесной связи с диагностикой ХП. Отражены подходы к терапии СД типа 3с в зависимости от его конкретной причины с особой значимостью коррекции экзокринной панкреатической недостаточности. Обосновано многообразие клинических подвариантов СД типа 3с с различной степенью нарушений углеводного обмена, что предполагает возможность разных схем сахароснижающей терапии. При отсутствии конкретных алгоритмов рассматриваются принципы управления гипергликемией в сравнении с СД типов 1 и 2: возможности и ограничения неинсулиновых сахароснижающих препаратов и принципы инсулинотерапии.</p></abstract><trans-abstract xml:lang="en"><p>An accurate differential diagnosis of the type of diabetes mellitus (DM) is one of the important conditions for a personalized choice of adequate therapy in modern diabetology. In this regard, particular attention is paid to the secondary diabetes due to a whole group of heterogeneous exocrine pancreatic diseases resulting from different pathogenesis, which are combined for classification purposes with chronic pancreatitis (CP) taking the leading role. The literature review presents an integral view of the problem based on an analysis of modern diabetological and gastroenterological guidelines. It discloses terminological transformation of this diabetes into type 3c diabetes and discusses the problem of assessing prevalence of type 3c diabetes. Clinical features are considered in close connection with pathogenetic, which makes it possible to represent type 3c DM as a special morphofunctional disorder with an emphasis on high risk of ductal adenocarcinoma of the pancreatic gland. The complexity of its verification is discussed in close connection with the diagnosis of СP. The article describes the approaches to the therapy of type 3c diabetes depending on its specific cause and emphasises the special significance of correction of exocrine pancreatic deficiency. It substantiates the variety of clinical subtypes of type 3c diabetes with different degrees of carbohydrate metabolism disorders, which suggests the use of various hypoglycemic therapy regimens. In the absence of specific algorithms, it discusses the principles of monitoring hyperglycaemia compared with those for type 1 and 2 diabetes: possibilities and limitations of non-insulin hypoglycemic drugs and the principles of insulin therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>панкреатогенный диабет</kwd><kwd>сахарный диабет типа 3с</kwd><kwd>хронический панкреатит</kwd><kwd>протоковая аденокарцинома поджелудочной железы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pancreatogenic diabetes</kwd><kwd>type 3c diabetes</kwd><kwd>chronic pancreatitis</kwd><kwd>ductal pancreatic adenocarcinoma</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev, 2012 May, 28(4): 338-42. doi: 10.1002/dmrr.2260.</mixed-citation><mixed-citation xml:lang="en">Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev, 2012 May, 28(4): 338-42. doi: 10.1002/dmrr.2260.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Malka D, Hammel P, Sauvanet A, Rufat P, O’Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Lévy P. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology, 2000 Nov, 119(5): 1324-32.</mixed-citation><mixed-citation xml:lang="en">Malka D, Hammel P, Sauvanet A, Rufat P, O’Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Lévy P. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology, 2000 Nov, 119(5): 1324-32.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Angelopoulos N, Dervenis C, Goula A, Rombopoulos G, Livadas S, Kaltsas D, Kaltzidou V, Tolis G. Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology, 2005, 5(23): 122-31. doi: 10.1159/000085264</mixed-citation><mixed-citation xml:lang="en">Angelopoulos N, Dervenis C, Goula A, Rombopoulos G, Livadas S, Kaltsas D, Kaltzidou V, Tolis G. Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology, 2005, 5(23): 122-31. doi: 10.1159/000085264</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Choudhuri G1, Lakshmi CP, Goel A. Pancreatic diabetes. Trop Gastroenterol, 2009 Apr-Jun, 30(2): 71-5.</mixed-citation><mixed-citation xml:lang="en">Choudhuri G1, Lakshmi CP, Goel A. Pancreatic diabetes. Trop Gastroenterol, 2009 Apr-Jun, 30(2): 71-5.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Perusicová J. Diabetes mellitus in chronic pancreatitis. Vnitr Lek, 2004 May, 50(5): 375-8.</mixed-citation><mixed-citation xml:lang="en">Perusicová J. Diabetes mellitus in chronic pancreatitis. Vnitr Lek, 2004 May, 50(5): 375-8.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2006 Jan, 29(suppl 1): 43-48.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2006 Jan, 29(suppl 1): 43-48.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2011 Jan, 34(Suppl 1): 62–69.doi: 10.2337/dc11-S062.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2011 Jan, 34(Suppl 1): 62–69.doi: 10.2337/dc11-S062.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. PancreasFest Recommendation Conference Participants. Pancreatology, 2013, 13(4): 336-42. doi: 10.1016/j.pan.2013.05.002.</mixed-citation><mixed-citation xml:lang="en">Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. PancreasFest Recommendation Conference Participants. Pancreatology, 2013, 13(4): 336-42. doi: 10.1016/j.pan.2013.05.002.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Phil A Hart, Melena D Bellin, Dana K Andersen, David Bradley, Zobeida Cruz-Monserrate, Christopher E Forsmark, Mark O Goodarzi, Aida Habtezion, Murray Korc, Yogish C Kudva, Stephen J Pandol, Dhiraj Yadav, and Suresh T Chari, on behalf of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol, 2016 Nov, 1(3): 226–237. doi: 10.1016/S2468-1253(16)30106-6.</mixed-citation><mixed-citation xml:lang="en">Phil A Hart, Melena D Bellin, Dana K Andersen, David Bradley, Zobeida Cruz-Monserrate, Christopher E Forsmark, Mark O Goodarzi, Aida Habtezion, Murray Korc, Yogish C Kudva, Stephen J Pandol, Dhiraj Yadav, and Suresh T Chari, on behalf of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol, 2016 Nov, 1(3): 226–237. doi: 10.1016/S2468-1253(16)30106-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ewald N, Hardt PD. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol, 2013, 19(42): 7276-7281.</mixed-citation><mixed-citation xml:lang="en">Ewald N, Hardt PD. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol, 2013, 19(42): 7276-7281.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации «Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 8-й выпуск. Сахарный диабет, 2017, 20(1S): 1-112. doi: 10.14341/DM20171S8</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines on algorithms of specialized medical care for patients with diabetes mellitus. Edited by Dedova II, Shestakova MV, Mayorova AYu. 8th issue. Sakharnyy Diabet, 2017, 20 (1S): 1-112. doi: 10.14341 / DM20171S8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology, 2011, 11(3): 279-94. doi: 10.1159/000329188.</mixed-citation><mixed-citation xml:lang="en">Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology, 2011, 11(3): 279-94. doi: 10.1159/000329188.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Whitcomb DC, Frulloni L, Garg P, Greer JB, Schneider A, Yadav D, Shimosegawa T. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology, 2016 Mar-Apr, 16(2): 218-24. doi: 10.1016/j.pan.2016.02.001.</mixed-citation><mixed-citation xml:lang="en">Whitcomb DC, Frulloni L, Garg P, Greer JB, Schneider A, Yadav D, Shimosegawa T. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology, 2016 Mar-Apr, 16(2): 218-24. doi: 10.1016/j.pan.2016.02.001.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sheth SG, Conwell DL, Whitcomb DC, Alsante M, Anderson MA, Barkin J, Brand R, Cote GA, Freedman SD, Gelrud A, Gorelick F, Lee LS, Morgan K, Pandol S, Singh VK, Yadav D, Wilcox CM, Hart PA. Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest. Pancreatology, 2017, 17(3): 419430. doi: 10.1016/j.pan.2017.02.015.</mixed-citation><mixed-citation xml:lang="en">Sheth SG, Conwell DL, Whitcomb DC, Alsante M, Anderson MA, Barkin J, Brand R, Cote GA, Freedman SD, Gelrud A, Gorelick F, Lee LS, Morgan K, Pandol S, Singh VK, Yadav D, Wilcox CM, Hart PA. Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest. Pancreatology, 2017, 17(3): 419430. doi: 10.1016/j.pan.2017.02.015.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency -Breaking the myths. BMC Med, 2017 Feb 10, 15(1): 29. doi: 10.1186/s12916-017-0783-y.</mixed-citation><mixed-citation xml:lang="en">Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency -Breaking the myths. BMC Med, 2017 Feb 10, 15(1): 29. doi: 10.1186/s12916-017-0783-y.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Singh VK, Haupt ME, Geller DE, Hall JA, Quintana Diez. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol, 2017 Oct 21, 23(39): 7059-7076. doi: 10.3748/wjg.v23.i39.7059.</mixed-citation><mixed-citation xml:lang="en">Singh VK, Haupt ME, Geller DE, Hall JA, Quintana Diez. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol, 2017 Oct 21, 23(39): 7059-7076. doi: 10.3748/ wjg.v23.i39.7059.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lew D, Afghani E, Pando S. Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci, 2017, 62(7): 1702– 1712. doi: 10.1007/s10620-017-4602-2.</mixed-citation><mixed-citation xml:lang="en">Lew D, Afghani E, Pando S. Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci, 2017, 62(7): 1702– 1712. doi: 10.1007/s10620-017-4602-2.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gudipaty L and Rickels MR. Pancreatogenic (Type 3c) Diabetes. Pancreapedia: Exocrine Pancreas Knowledge Base. 2015. doi: 10.3998/panc.2015.35.</mixed-citation><mixed-citation xml:lang="en">Gudipaty L and Rickels MR. Pancreatogenic (Type 3c) Diabetes. Pancreapedia: Exocrine Pancreas Knowledge Base. 2015. doi: 10.3998/panc.2015.35.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ребров А.П., Куницына М.А., Кашкина Е.И., Архангельская Е.Е. Панкреатогенный сахарный диабет: актуальные проблемы патогенеза и лечения (обзор). Саратовский научномедицинский журнал, 2012, 8(3): 862-867.</mixed-citation><mixed-citation xml:lang="en">Rebrov AP, Kunitsyna MA, Kashkina EI, Arkhangelskaya EE. Pancreatogenic diabetes mellitus: topical problems of pathogenesis and treatment (review). Saratovskiy NauchnoMeditsinskiy Zhurnal, 2012, 8 (3): 862-867.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Niebisz-Cieślak AB and Karnafel W. Insulin sensitivity in chronic pancreatitis and features of insulin resistance syndrome. Pol Arch Med Wewn, 2010, 120: 255–263.</mixed-citation><mixed-citation xml:lang="en">Niebisz-Cieślak AB and Karnafel W. Insulin sensitivity in chronic pancreatitis and features of insulin resistance syndrome. Pol Arch Med Wewn, 2010, 120: 255–263.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Brereton MF, Vergari E, Zhang Q, Clark A. Alpha-, Deltaand PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination? J Histochem Cytochem, 2015 Aug, 63(8): 575–591. doi: 10.1369/0022155415583535.</mixed-citation><mixed-citation xml:lang="en">Brereton MF, Vergari E, Zhang Q, Clark A. Alpha-, Deltaand PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination? J Histochem Cytochem, 2015 Aug, 63(8): 575–591. doi: 10.1369/0022155415583535.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Прощина А.Е., Кривова Ю.С., Барабанов В.М., Савельев С.В. Иммуногистохимическое исследование наиболее крупных островков поджелудочной железы человека при старении и при сахарном диабете 1 и 2 типов, перспективы для трансплантации. Сахарный диабет, 2013, (4): 38–43.</mixed-citation><mixed-citation xml:lang="en">Proshina AE, Krivova YuS, Barabanov VM, Savelyev SV. Immunohistochemical study of the largest islets of the human pancreas in aging and type 1 and 2 diabetes mellitus, prospects for transplantation. Sakharnyy Diabet, 2013, (4): 38-43.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis, aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 2010, 24: 349–358. doi: 10.1016/j.bpg.2010.02.007.</mixed-citation><mixed-citation xml:lang="en">Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis, aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 2010, 24: 349–358. doi: 10.1016/j.bpg.2010.02.007.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Andersen DK, Andren-Sandberg A, Duell EJ, et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas, 2013, 42: 1227–1237. doi: 10.1097/MPA.0b013e3182a9ad9d.</mixed-citation><mixed-citation xml:lang="en">Andersen DK, Andren-Sandberg A, Duell EJ, et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas, 2013, 42: 1227–1237. doi: 10.1097/MPA.0b013e3182a9ad9d.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken or egg? Pancreas, 2011, 40(3): 339–351. doi: 10.1097/MPA.0b013e318209e05d</mixed-citation><mixed-citation xml:lang="en">Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken or egg? Pancreas, 2011, 40(3): 339–351. doi: 10.1097/ MPA.0b013e318209e05d</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Eibl G, Cruz-Monserrate Z, Korc M, Petrov MS, Goodarzi MO, Fisher WE, Habtezion A, Lugea A, Pandol SJ, Hart PA, Andersen DK, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. J Acad Nutr Diet, 2017 Sep 11, pii: S2212-2672(17)31087-0. doi: 10.1016/j.jand.2017.07.005.</mixed-citation><mixed-citation xml:lang="en">Eibl G, Cruz-Monserrate Z, Korc M, Petrov MS, Goodarzi MO, Fisher WE, Habtezion A, Lugea A, Pandol SJ, Hart PA, Andersen DK, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. J Acad Nutr Diet, 2017 Sep 11, pii: S2212-2672(17)31087-0. doi: 10.1016/j.jand.2017.07.005.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c) Are we neglecting an important disease? Eur J Intern Med, 2013, 24: 203-206. PMID: 23375619.</mixed-citation><mixed-citation xml:lang="en">Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c) Are we neglecting an important disease? Eur J Intern Med, 2013, 24: 203-206. PMID: 23375619.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, Chari ST, Abbruzzese J L. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes, 2017 May, 66(5): 1103-1110. doi: 10.2337/db16-1477.</mixed-citation><mixed-citation xml:lang="en">Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, Chari ST, Abbruzzese J L. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes, 2017 May, 66(5): 1103-1110. doi: 10.2337/db16-1477.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis. Gastroenterology, Report of the Second International Symposium on the classification of pancreatitis in Marseille, France. March 28–30, 1984, 1985: 683–685.</mixed-citation><mixed-citation xml:lang="en">Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis. Gastroenterology, Report of the Second International Symposium on the classification of pancreatitis in Marseille, France. March 28–30, 1984, 1985: 683–685.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Yadav D, O’Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol, 2012, 107: 1096– 1103. doi: 10.1038/ajg.2012.126.</mixed-citation><mixed-citation xml:lang="en">Yadav D, O’Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol, 2012, 107: 1096– 1103. doi: 10.1038/ajg.2012.126.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B, CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 2010 Dec, 33(12): 2697-708. doi: 10.2337/dc10-1768.</mixed-citation><mixed-citation xml:lang="en">Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B, CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 2010 Dec, 33(12): 2697-708. doi: 10.2337/dc10-1768.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Makuc J. Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab Syndr Obes, 2016, 9: 311–315. doi: 10.2147/DMSO.S99701.</mixed-citation><mixed-citation xml:lang="en">Makuc J. Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab Syndr Obes, 2016, 9: 311–315. doi: 10.2147/ DMSO.S99701.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP, 2009, 10: 387–392.</mixed-citation><mixed-citation xml:lang="en">Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP, 2009, 10: 387–392.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine, 2015, 2: 1996–2002. doi: 10.1016/j.ebiom.2015.11.023.</mixed-citation><mixed-citation xml:lang="en">Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine, 2015, 2: 1996–2002. doi: 10.1016/j.ebiom.2015.11.023.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Setiawan VW, Pandol SJ, Porcel J, et al. Prospective study of alcohol drinking, smoking, and pancreatitis: the multiethnic cohort. Pancreas, 2016, 45: 819–825.</mixed-citation><mixed-citation xml:lang="en">Setiawan VW, Pandol SJ, Porcel J, et al. Prospective study of alcohol drinking, smoking, and pancreatitis: the multiethnic cohort. Pancreas, 2016, 45: 819–825.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Sikkens EC, Cahen DL, Koch AD, Braat H, Poley JW, Kuipers EJ, Bruno MJ. The prevalence of fatsoluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology, 2013, 13: 238–242. DOI: 10.1016/j.pan.2013.02.008.</mixed-citation><mixed-citation xml:lang="en">Sikkens EC, Cahen DL, Koch AD, Braat H, Poley JW, Kuipers EJ, Bruno MJ. The prevalence of fatsoluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology, 2013, 13: 238–242. DOI: 10.1016/j.pan.2013.02.008.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Conlon KC, Duggan SN. Pancreatogenic Type 3c Diabetes: Underestimated, Underappreciated and Poorly Managed. Practical gastroenterology, 2017, serias#163. med.virginia.edu. https://med.virginia.edu/ginutrition/wp-content/ uploads/sites/199/2014/06/Parrish-May-17.pdf.</mixed-citation><mixed-citation xml:lang="en">Conlon KC, Duggan SN. Pancreatogenic Type 3c Diabetes: Underestimated, Underappreciated and Poorly Managed. Practical gastroenterology, 2017, serias#163. med.virginia.edu. https: // med.virginia.edu/ginutrition/wp-content/ uploads/sites/199/2014/06/Parrish-May-17.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">De-madaria E, Abad-gonzález A, Aparicio JR, et al. The Spanish Pancreatic Club’s recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology. 2013, 13: 18–28. doi: http://dx.doi.org/10.1016/j.pan.2012.11.310.</mixed-citation><mixed-citation xml:lang="en">De-madaria E, Abad-gonzález A, Aparicio JR, et al. The Spanish Pancreatic Club’s recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology. 2013, 13: 18–28. doi: http: //dx.doi. org/10.1016/j.pan.2012.11.310.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bellin MD, Freeman ML, Gelrud A, et al. Total pancreatectomy and islet auto transplantation in chronic pancreatitis: recommendations from PancreasFest. Pancreatology, 2014, 14: 27–35.</mixed-citation><mixed-citation xml:lang="en">Bellin MD, Freeman ML, Gelrud A, et al. Total pancreatectomy and islet auto transplantation in chronic pancreatitis: recommendations from PancreasFest. Pancreatology, 2014, 14: 27–35.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Knop FK, Vilsbøll T, Larsen S, Højberg PV, Vølund A, Madsbad S, Holst JJ, Krarup T. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab, 2007 Jan, 292(1): E324-30. DOI: 10.1152/ajpendo.00059.2006.</mixed-citation><mixed-citation xml:lang="en">Knop FK, Vilsbøll T, Larsen S, Højberg PV, Vølund A, Madsbad S, Holst JJ, Krarup T. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab, 2007 Jan, 292(1): E324-30. DOI: 10.1152/ajpendo.00059.2006.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Meier JJ, Giese A Diabetes associated with pancreatic diseases. Curr Opin Gastroenterol, 2015 Sep, 31(5): 400-6. doi: 10.1097/MOG.0000000000000199.</mixed-citation><mixed-citation xml:lang="en">Meier JJ, Giese A Diabetes associated with pancreatic diseases. Curr Opin Gastroenterol, 2015 Sep, 31(5): 400-6. doi: 10.1097/MOG.0000000000000199.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Das S, Tripathy SK, Panda BP. Pancreatic Diabetes. Medicine Update, 2017. Section 18: Diabetes, 757-761. https: //issuu.com/urvitrivedi/docs/18_diabetes/1?ff=true.</mixed-citation><mixed-citation xml:lang="en">Das S, Tripathy SK, Panda BP. Pancreatic Diabetes. Medicine Update, 2017. Section 18: Diabetes, 757-761. https: //issuu.com/urvitrivedi/docs/18_diabetes/1?ff=true.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2009 Jan, 32(1): 193-203.</mixed-citation><mixed-citation xml:lang="en">Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2009 Jan, 32(1): 193-203.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Руяткина Л.А., Руяткин Д.С. Многоплановые эффекты метформина у пациентов с сахарным диабетом 2 типа. Сахарный диабет, 2017, 20(3): 210-219. doi: 10.14341/DM8676.</mixed-citation><mixed-citation xml:lang="en">Ruyatkina LA, Ruyutkin DS. Multi-faceted effects of metformin in patients with type 2 diabetes mellitus. Sakharnyy Diabet, 2017, 20 (3): 210-219. doi: 10.14341 / DM8676.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Lai ST, Xie L, Zhao JD, Ma NY, Zhu J, Ren ZG, Jiang GL. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract, 2014 Oct, 106(1): 19-26. doi: 10.1016/j.diabres.2014.04.007.</mixed-citation><mixed-citation xml:lang="en">Wang Z, Lai ST, Xie L, Zhao JD, Ma NY, Zhu J, Ren ZG, Jiang GL. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract, 2014 Oct, 106(1): 19-26. doi: 10.1016/j. diabres.2014.04.007.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Dong YW, Shi YQ, He LW, Cui XY, Su PZ. Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis. Oncotarget, 2017 May 26, 8(33): 55478-55488. doi: 10.18632/oncotarget.18233.</mixed-citation><mixed-citation xml:lang="en">Dong YW, Shi YQ, He LW, Cui XY, Su PZ. Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis. Oncotarget, 2017 May 26, 8(33): 55478-55488. doi: 10.18632/ oncotarget.18233.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Kowall B, Rathmann W, Kostev K. Are Sulfonylurea and Insulin Therapies Associated With a Larger Risk of Cancer Than Metformin Therapy? A Retrospective Database Analysis. Diabetes Care, 2015, 38(1): 59-65.</mixed-citation><mixed-citation xml:lang="en">Kowall B, Rathmann W, Kostev K. Are Sulfonylurea and Insulin Therapies Associated With a Larger Risk of Cancer Than Metformin Therapy? A Retrospective Database Analysis. Diabetes Care, 2015, 38(1): 59-65.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Li T, Liu Z, Gou S, Wang C The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis. Sci Rep, 2017 Jul 19, 7(1): 5825. doi: 10.1038/s41598-017-06207-x.</mixed-citation><mixed-citation xml:lang="en">Li X, Li T, Liu Z, Gou S, Wang C The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis. Sci Rep, 2017 Jul 19, 7(1): 5825. doi: 10.1038/s41598-017-06207-x.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Yang JY, Kweon MN. The gut microbiota: a key regulator of metabolic diseases. BMB Rep, 2016 Oct, 49(10): 536-541.</mixed-citation><mixed-citation xml:lang="en">Yang JY, Kweon MN. The gut microbiota: a key regulator of metabolic diseases. BMB Rep, 2016 Oct, 49(10): 536-541.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Hur KY, Lee MS. New mechanisms of metformin action: Focusing on mitochondria and the gut. J Diabetes Investig, 2015, 6(6): 600–609. doi: 10.1111/jdi.12328.</mixed-citation><mixed-citation xml:lang="en">Hur KY, Lee MS. New mechanisms of metformin action: Focusing on mitochondria and the gut. J Diabetes Investig, 2015, 6(6): 600–609. doi: 10.1111/jdi.12328.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Jandhyala SM, Madhulika A, Deepika G, Rao GV, Reddy DN, Subramanyam C, Sasikala M, Talukdar R. Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Scientific Reports, 2017, 3(7): 43640. doi: 10.1038/srep43640.</mixed-citation><mixed-citation xml:lang="en">Jandhyala SM, Madhulika A, Deepika G, Rao GV, Reddy DN, Subramanyam C, Sasikala M, Talukdar R. Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Scientific Reports, 2017, 3(7): 43640. doi: 10.1038/srep43640.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Tilg H, Moschen AR. Microbiota and Diabetes: An Evolving Relationship. Gut, 2014, 63(9): 1513-21. doi: 10.1136/gutjnl-2014-306928.</mixed-citation><mixed-citation xml:lang="en">Tilg H, Moschen AR. Microbiota and Diabetes: An Evolving Relationship. Gut, 2014, 63(9): 1513-21. doi: 10.1136/gutjnl-2014-306928.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Sola D, Rossi L, Schianca GPC, Maffioli P, Bigliocca M, Mella R, Corlianò F, Fra G.P, Bartoli E, and Derosa G. Sulfonylureas and their use in clinical practice. Arch Med Sci, 2015 Aug 12, 11(4): 840–848. doi: 10.5114/aoms.2015.53304.</mixed-citation><mixed-citation xml:lang="en">Sola D, Rossi L, Schianca GPC, Maffioli P, Bigliocca M, Mella R, Corlianò F, Fra G.P, Bartoli E, and Derosa G. Sulfonylureas and their use in clinical practice. Arch Med Sci, 2015 Aug 12, 11(4): 840–848. doi: 10.5114/aoms.2015.53304.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Lee YH, Lee BW, Chun SW, Cha BS, Lee HC. Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure. Int J Clin Pract, 2011 Oct, 65(10): 1076-84. doi: 10.1111/j.1742-1241.2011.02755.</mixed-citation><mixed-citation xml:lang="en">Lee YH, Lee BW, Chun SW, Cha BS, Lee HC. Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure. Int J Clin Pract, 2011 Oct, 65(10): 1076-84. doi: 10.1111/j.1742-1241.2011.02755.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Knop FK. Incretin hormones and beta cell function in chronic pancreatitis. Dan Med Bull, 2010 Jul, 57(7): B4163.</mixed-citation><mixed-citation xml:lang="en">Knop FK. Incretin hormones and beta cell function in chronic pancreatitis. Dan Med Bull, 2010 Jul, 57(7): B4163.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Iyer SN, Tanenberg RJ, Mendez CE, West RL, Drake AJ .Pancreatitis associated with incretinbased therapies. Diabetes Care, 2013 Apr, 36(4): e49. doi: 10.2337/dc12-1987.</mixed-citation><mixed-citation xml:lang="en">Iyer SN, Tanenberg RJ, Mendez CE, West RL, Drake AJ .Pancreatitis associated with incretinbased therapies. Diabetes Care, 2013 Apr, 36(4): e49. doi: 10.2337/dc12-1987.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Egan A, et al. Pancreatic safety of incretinbased drugs – FDA and EMA assessment. N Engl J Med, 2014, 370: 794–6.</mixed-citation><mixed-citation xml:lang="en">Egan A, et al. Pancreatic safety of incretinbased drugs – FDA and EMA assessment. N Engl J Med, 2014, 370: 794–6.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Gerstein HC, Bosch J, Dagenais GR, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med, 2012, 367(4): 319-328.</mixed-citation><mixed-citation xml:lang="en">Gerstein HC, Bosch J, Dagenais GR, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med, 2012, 367(4): 319-328.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: A consensus report. Diabetes Care, 2010, 33(7): 1674-1685.</mixed-citation><mixed-citation xml:lang="en">Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: A consensus report. Diabetes Care, 2010, 33(7): 1674-1685.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
